Adverse Events Following Haemophilus influenzae Type b (Hib) Monovalent Vaccines in Zhejiang Province, China, from 2017 to 2023
Our findings provide preliminary evidence of the safety profile of the Hib vaccine at a provincial level, which adds further support for its broader implementation in other provinces. Future multi-center studies are needed to construct a comprehensive vaccine evaluation framework and make multi-criteria decisions on the feasibility of incorporating the Hib vaccine into China's NIP.
Authors
- Xuejiao Pan (ORCID: https://orcid.org/0000-0003-2418-3174)
- Linzhi Shen
- Chen Ya-ping (ORCID: https://orcid.org/0000-0001-6595-3230)
- Hui Liang (ORCID: https://orcid.org/0000-0002-0675-6963)
- Xiaohua Qi
Institutions
- Zhejiang Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Vaccines
- Published
- 2025-03-25
- DOI
- https://doi.org/10.3390/vaccines13040349
- Citations
- 2
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 4.33